van der Velden PA - Search Results

1

Triamcinolone acetonide and anecortave acetate do not stimulate uveal melanoma cell growth.

El Filali M, Homminga I, Maat W, van der Velden PA, Jager MJ. El Filali M, et al. Among authors: van der velden pa. Mol Vis. 2008 Sep 24;14:1752-9. Mol Vis. 2008. PMID: 18836566 Free PMC article.

2

Promoter hypermethylation: a common cause of reduced p16(INK4a) expression in uveal melanoma.

van der Velden PA, Metzelaar-Blok JA, Bergman W, Monique H, Hurks H, Frants RR, Gruis NA, Jager MJ. van der Velden PA, et al. Cancer Res. 2001 Jul 1;61(13):5303-6. Cancer Res. 2001. PMID: 11431374

3

Expression profiling reveals that methylation of TIMP3 is involved in uveal melanoma development.

van der Velden PA, Zuidervaart W, Hurks MHMH, Pavey S, Ksander BR, Krijgsman E, Frants RR, Tensen CP, Willemze R, Jager MJ, Gruis NA. van der Velden PA, et al. Int J Cancer. 2003 Sep 10;106(4):472-479. doi: 10.1002/ijc.11262. Int J Cancer. 2003. PMID: 12845640

4

Gene expression profiling identifies tumour markers potentially playing a role in uveal melanoma development.

Zuidervaart W, van der Velden PA, Hurks MH, van Nieuwpoort FA, Out-Luiting CJ, Singh AD, Frants RR, Jager MJ, Gruis NA. Zuidervaart W, et al. Among authors: van der velden pa, van nieuwpoort fa. Br J Cancer. 2003 Nov 17;89(10):1914-9. doi: 10.1038/sj.bjc.6601374. Br J Cancer. 2003. PMID: 14612903 Free PMC article.

5

Activation of the MAPK pathway is a common event in uveal melanomas although it rarely occurs through mutation of BRAF or RAS.

Zuidervaart W, van Nieuwpoort F, Stark M, Dijkman R, Packer L, Borgstein AM, Pavey S, van der Velden P, Out C, Jager MJ, Hayward NK, Gruis NA. Zuidervaart W, et al. Br J Cancer. 2005 Jun 6;92(11):2032-8. doi: 10.1038/sj.bjc.6602598. Br J Cancer. 2005. PMID: 15928660 Free PMC article.

6

Epigenetic inactivation of RASSF1a in uveal melanoma.

Maat W, van der Velden PA, Out-Luiting C, Plug M, Dirks-Mulder A, Jager MJ, Gruis NA. Maat W, et al. Among authors: van der velden pa. Invest Ophthalmol Vis Sci. 2007 Feb;48(2):486-90. doi: 10.1167/iovs.06-0781. Invest Ophthalmol Vis Sci. 2007. PMID: 17251440

7

Pyrophosphorolysis detects B-RAF mutations in primary uveal melanoma.

Maat W, Kilic E, Luyten GP, de Klein A, Jager MJ, Gruis NA, Van der Velden PA. Maat W, et al. Among authors: van der velden pa. Invest Ophthalmol Vis Sci. 2008 Jan;49(1):23-7. doi: 10.1167/iovs.07-0722. Invest Ophthalmol Vis Sci. 2008. PMID: 18172070

8

Epigenetic regulation identifies RASEF as a tumor-suppressor gene in uveal melanoma.

Maat W, Beiboer SH, Jager MJ, Luyten GP, Gruis NA, van der Velden PA. Maat W, et al. Among authors: van der velden pa. Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1291-8. doi: 10.1167/iovs.07-1135. Invest Ophthalmol Vis Sci. 2008. PMID: 18385040

9

Methylation in uveal melanoma.

van der Velden PA, Maat W. van der Velden PA, et al. Br J Ophthalmol. 2009 Jan;93(1):132. doi: 10.1136/bjo.2008.144238. Epub 2008 Jul 23. Br J Ophthalmol. 2009. PMID: 18650211 No abstract available.

10

Episodic Src activation in uveal melanoma revealed by kinase activity profiling.

Maat W, el Filali M, Dirks-Mulder A, Luyten GP, Gruis NA, Desjardins L, Boender P, Jager MJ, van der Velden PA. Maat W, et al. Among authors: van der velden pa. Br J Cancer. 2009 Jul 21;101(2):312-9. doi: 10.1038/sj.bjc.6605172. Epub 2009 Jun 30. Br J Cancer. 2009. PMID: 19568237 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters